CSR rules notified by MCA; multi-year projects allowed with a time-limit of three years
Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events
In an interaction with beneficiaries from his constituency, PM assures both vaccines safe
According to reports, Modi is likely to take the vaccine in the second phase when it is the turn of front-line workers to get the shot
Prime Minister Narendra Modi expressed anguish over the incident
Ministry hopeful of uptick in activity; may take Rs 12k-crore loan from Nabard
Provisional vaccination certificate for first dose, followed by a final certificate after the second
India may start vaccine exports as soon as today
Healthcare workers must endorse the inoculation, declining will be matter of sadness: Government officials
The top court also clarified that a company which is facing insolvency proceedings under the IBC can move an insolvency petition against other companies which owe it money
Two deaths were reported in Uttar Pradesh and Karnataka, one not linked to jab, the other yet to be investigated
Many adoopt wait-and-watch approach as confidence about safety and efficacy of the jab is low
Health Ministry said that it had received complaints of the Co-WIN digital platform being slow
India's vaccination drive is based on principles of humanity, says the prime minister
Under the emergency use authorisation, the vaccine is only for those above 18 years of age
Over 3,000 sites across the country ready to vaccinate 300,000 health workers on first day. Some 100 beneficiaries will be given jab at each session site
The decision of Drugs Controller General of India to allow accelerated approval or the emergency use approval for Covaxin had become a contentious issue
People can't choose between Covishield & Covaxin, says govt; vaccine to take effect two weeks after the second dose
CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.
According to sources, a contract may be signed between the government and the vaccine makers on Monday, and the first batch of vaccinations will be done using Serum Institute's (SII's) Covishield